Johnson & Johnson upgraded at Goldman Sachs
March 14, 2016 at 10:35 AM EDT
Johnson & Johnson was upgraded at Goldman Sachs, which urged “bold” reorganizational moves that open up untapped shareholder value of up to $40 billion for the health care company.
